Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Feasibility Study of FOLFOX4 Regimen for Advanced Colorectal Cancer
jRCT2080220117
- Sponsor
- Yakult Honsha
- Start
- Sep 2005
- Modality
- Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of oxaliplatin, fluorouracil and levoleucovorin in colorectal cancer (CRC), sponsored by Yakult Honsha.
02
Drugs
oxaliplatinfluorouracillevoleucovorin
03
Conditions
colorectal cancer (CRC)
Beyond the preview
Go deeper on jRCT2080220117.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220117.